A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.
Quadruple-threat Rheumatologist
In Norway and on the international front, Tore Kvien, MD, PhD, has propelled clinical research to new levels
Competition on Another Pitch: Capture the World Cup Spirit to Drive Rheumatology Discovery
Capture the World Cup spirit to drive rheumatology discovery
REF’s Campaign to Support RA Research Nears its Initial Funding Target
The REF’s campaign to support RA research nears its initial funding target
Mitigate Risk and Increase Success of Lupus Clinical Trials
Design strategies from a Lupus Research Institute conference
Within Our Reach: Collaborating to Find a Cure for RA
Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.
Recent Study Improves Understanding of Preclinical Rheumatoid Arthritis
A study recently published in Arthritis Care & Research (AC&R) reveals a novel approach for the study of preclinical rheumatoid arthritis (RA). The investigators conducting the study sought to determine if these RA-related biomarkers could also be found in healthy subjects in order to investigate relationships between genetic and environmental factors and the presence of these biomarkers. Their goal is to study how these biomarkers evolve.
When Lupus Research is a Family Affair
Following sisters of SLE patients may shed light on risk factors and progression of the disease
Health Professional Careers in Rheumatology Research
Robert McLean, DSc, MPH, is an assistant research scientist at the Hebrew SeniorLife Institute for Aging Research in Boston, and his primary research interests lie in the epidemiology of osteoporosis and related fractures. After working in epidemiology for over 10 years, Dr. McLean recently established himself as an independent investigator without significant prior research experience, thanks to the help of an REF research award designed specifically for early career investigators.
Decode the Crosstalk Between Bones, Brain, and Fat
Leptin inhibits serotonin synthesis in the neurons of the brainstem
- « Previous Page
- 1
- …
- 64
- 65
- 66
- 67
- 68
- …
- 77
- Next Page »